猝睡症:全球臨床實驗檢討

本報告提供全球各國猝睡症的臨床實驗的相關調查，各地區、進展狀況、各階段、各募集情況的實驗量，代表性贊助商，正在開發的治療藥物的資訊，各企業機關的進行狀況等資訊彙整，為您概述為以下內容。

Abstract

Narcolepsy Global Clinical Trials Review, H2, 2012

Summary

GlobalData's clinical trial report, "Narcolepsy Global Clinical Trials Review, H2, 2012" provides data on the Narcolepsy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Narcolepsy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Narcolepsy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Narcolepsy Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Narcolepsy, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

TOC

Table of Contents

Table of Contents 2

• List of Tables 4
• List of Figures 5
• Introduction 6
• Narcolepsy 6
• Report Guidance 6
• Clinical Trials by Region 7
• Clinical Trials by Country 8
• Top Countries Contributing to Clinical Trials in Asia-Pacific 10
• Top Five Countries Contributing to Clinical Trials in Europe 11
• Top Countries Contributing to Clinical Trials in North America 12
• Top Countries Contributing to Clinical Trials in Middle East and Africa 13
• Top Countries Contributing to Clinical Trials in Central and South America 14
• Clinical Trials by BRIC Nations 15
• Clinical Trials by G7 Nations 16
• Clinical Trials in G7 Nations by Trial Status 17
• Clinical Trials by E7 Nations 18
• Clinical Trials in E7 Nations by Trial Status 19
• Clinical Trials by Phase 20
• In Progress Trials by Phase 21
• Clinical Trials by Trial Status 22
• Unaccomplished Trials of Narcolepsy 23
• Subjects Recruited Over a Period of Time 24
• Prominent Sponsors 25
• Top Companies Participating in Narcolepsy Therapeutics Clinical Trials 27
• Prominent Drug Comparison 29
• Clinical Trial Profiles 30
• Clinical Trial Overview of Top Companies 30
• Cephalon, Inc. 30
• Clinical Trial Overview of Cephalon, Inc. 30
• Orphan Medical, Inc. (Inactive) 31
• Clinical Trial Overview of Orphan Medical, Inc. (Inactive) 31
• UCB S.A. 32
• Clinical Trial Overview of UCB S.A. 32
• BIOPROJET PHARMA SARL 33
• Clinical Trial Overview of BIOPROJET PHARMA SARL 33
• BIOPROJET SCR 34
• Clinical Trial Overview of BIOPROJET SCR 34
• Aerial BioPharma LLC 35
• Clinical Trial Overview of Aerial BioPharma LLC 35
• GlaxoSmithKline plc 36
• Clinical Trial Overview of GlaxoSmithKline plc 36
• Johnson & Johnson 37
• Clinical Trial Overview of Johnson & Johnson 37
• Orasi Medical, Inc. 38
• Clinical Trial Overview of Orasi Medical, Inc. 38
• Arena Pharmaceuticals, Inc. 39
• Clinical Trial Overview of Arena Pharmaceuticals, Inc. 39
• Sun Pharmaceutical Industries Limited 40
• Clinical Trial Overview of Sun Pharmaceutical Industries Limited 40
• Teva Pharmaceutical Industries Limited 41
• Clinical Trial Overview of Teva Pharmaceutical Industries Limited 41
• Pfizer Inc. 42
• Clinical Trial Overview of Pfizer Inc. 42
• Mylan Inc. 43
• Clinical Trial Overview of Mylan Inc. 43
• Clinical Trial Overview of Top Universities / Institutes / Hospitals 44
• Emory University 44
• Clinical Trial Overview of Emory University 44
• University of Arkansas 45
• Clinical Trial Overview of University of Arkansas 45
• Zentrum fur Integrative Psychiatrie 46
• Clinical Trial Overview of Zentrum fur Integrative Psychiatrie 46
• Brigham and Women's Hospital 47
• Clinical Trial Overview of Brigham and Women's Hospital 47
• Neuropsychiatric Research Institute 48
• Clinical Trial Overview of Neuropsychiatric Research Institute 48
• Hopital du Sacre-Coeur de Montreal 49
• Clinical Trial Overview of Hopital du Sacre-Coeur de Montreal 49
• National Taiwan University Hospital 50
• Clinical Trial Overview of National Taiwan University Hospital 50
• University Hospital, Bordeaux 51
• Clinical Trial Overview of University Hospital, Bordeaux 51
• Five Key Clinical Profiles 52

Appendix 83

• Abbreviations 83
• Definitions 83
• Research Methodology 84
• Secondary Research 84
• About GlobalData 85
• Contact Us 85
• Disclaimer 85
• Source 86

List of Tables

List of Tables

• Narcolepsy Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7
• Narcolepsy Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
• Narcolepsy Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
• Narcolepsy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 10
• Narcolepsy Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 11
• Narcolepsy Therapeutics Clinical Trials, North America, Top Countries, 2012* 12
• Narcolepsy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 13
• Narcolepsy Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 14
• Narcolepsy Therapeutics Clinical Trials, BRIC Countries, 2012* 15
• Narcolepsy Therapeutics Clinical Trials, G7 Countries, 2012* 16
• Narcolepsy Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 17
• Narcolepsy Therapeutics Clinical Trials, E7 Countries, 2012* 18
• Narcolepsy Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 19
• Narcolepsy Therapeutics Market, Global, Clinical Trials by Phase, 2012* 20
• Narcolepsy Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 21
• Narcolepsy Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 22
• Narcolepsy Therapeutics Market, Global, Terminated Clinical Trials, 2012* 23
• Narcolepsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 24
• Narcolepsy Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 26
• Narcolepsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 28
• Narcolepsy Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 29
• Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Cephalon, Inc., 2012* 30
• Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Orphan Medical, Inc. (Inactive), 2012* 31
• Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2012* 32
• Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by BIOPROJET PHARMA SARL, 2012* 33
• Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by BIOPROJET SCR, 2012* 34
• Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Aerial BioPharma LLC, 2012* 35
• Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 36
• Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012* 37
• Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Orasi Medical, Inc., 2012* 38
• Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Arena Pharmaceuticals, Inc., 2012* 39
• Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Pharmaceutical Industries Limited, 2012* 40
• Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2012* 41
• Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 42
• Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Mylan Inc., 2012* 43
• Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2012* 44
• Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Arkansas, 2012* 45
• Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Zentrum fur Integrative Psychiatrie, 2012* 46
• Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2012* 47
• Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Neuropsychiatric Research Institute, 2012* 48
• Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopital du Sacre-Coeur de Montreal, 2012* 49
• Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2012* 50
• Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bordeaux, 2012* 51

List of Figures

List of Figures

• Narcolepsy Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7
• Narcolepsy Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
• Narcolepsy Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
• Narcolepsy Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 10
• Narcolepsy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 11
• Narcolepsy Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 12
• Narcolepsy Therapeutics Clinical Trials, BRIC Countries (%), 2012* 15
• Narcolepsy Therapeutics Clinical Trials, G7 Countries (%), 2012* 16
• Narcolepsy Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 17
• Narcolepsy Therapeutics Clinical Trials, E7 Countries (%), 2012* 18
• Narcolepsy Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 20
• Narcolepsy Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 21
• Narcolepsy Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 22
• Narcolepsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 24
• Narcolepsy Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 25
• Narcolepsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 27
• Narcolepsy Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 29
• GlobalData Methodology 84